Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A notice was added announcing NIH website changes and explaining that the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence”.
    Difference
    0.7%
    Check dated 2026-10-26T14:25:22.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:11:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:28:18.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Added a new revision entry v3.7.0 to the study record history. The previous revision v3.6.6 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-21T22:17:56.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    A new revision (v3.6.6) was added to the study's history, replacing the previous revision (v3.6.5) and indicating an update to the record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-08-31T17:37:52.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The revision history now lists v3.6.5 instead of v3.6.4, reflecting a new interface release. This indicates an update to the ClinicalTrials.gov release notes for the page.
    Difference
    0.1%
    Check dated 2026-08-10T11:54:51.000Z thumbnail image

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.